Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-04T18:22:16.433Z Has data issue: false hasContentIssue false

Can curcumin modulate allergic rhinitis in rats?

Published online by Cambridge University Press:  06 October 2016

M Acar
Affiliation:
ENT, Yunus Emre State Hospital, Eskişehir, Turkey
N Bayar Muluk*
Affiliation:
ENT Department, Medical Faculty, Kırıkkale University, Turkey
S Yigitaslan
Affiliation:
Department of Pharmacology, Eskişehir Osmangazi University, Turkey
B P Cengiz
Affiliation:
Pathology Clinics, Yunus Emre State Hospital, Eskişehir, Turkey
P Shojaolsadati
Affiliation:
Department of Anatomy, Eskişehir Osmangazi University, Turkey
H Karimkhani
Affiliation:
Department of Biochemistry, Eskişehir Osmangazi University, Turkey
S Ada
Affiliation:
ENT Department, Luleburgaz State Hospital, Ankara, Turkey
M Berkoz
Affiliation:
Pharmaceutical Biotechnology Department, Faculty of Pharmacy, Yüzüncü Yıl University, Van, Turkey
C Cingi
Affiliation:
Department of ENT, Eskişehir Osmangazi University, Turkey
*
Address for correspondence: Dr Nuray Bayar Muluk, Birlik Mahallesi, Zirvekent 2. Etap Sitesi, C-3 blok, No: 62/43, 06610 Çankaya / ANKARA, Turkey Fax: +90 312 4964073 E-mail: [email protected]

Abstract

Objectives:

This study aimed to explore the effects of curcumin on experimental allergic rhinitis in rats.

Methods:

Twenty-eight male Wistar albino rats were randomly divided into four groups: a control group; a group in which allergic rhinitis was induced and no treatment given; a group in which allergic rhinitis was induced followed by treatment with azelastine hydrochloride on days 21–28; and a group in which allergic rhinitis was induced followed by treatment with curcumin on days 21–28. Allergy symptoms and histopathological features of the nasal mucosa were examined.

Results:

The sneezing and nasal congestion scores were higher in the azelastine and curcumin treatment groups than in the control group. Histopathological examination showed focal goblet cell metaplasia on the epithelial surface in the azelastine group. In the curcumin group, there was a decrease in goblet cell metaplasia in the epithelium, decreased inflammatory cell infiltration and vascular proliferation in the lamina propria.

Conclusion:

Curcumin is an effective treatment for experimentally induced allergic rhinitis in rats.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Owaga, EE, Mpondab, J, Nyang'injac, RA. Nutrigenomic approach in understanding the antiallergic effects of curcumin. Asian Journal of Biomedical and Pharmaceutical Sciences 2014;4:15 Google Scholar
2 Srivastava, RM, Singh, S, Dubey, SK, Misra, K, Khar, A. Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol 2011;11:331–41Google Scholar
3 Bousquet, J, Van Cauwenberge, P, Khaltaev, N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(suppl 5):S147S334 Google Scholar
4 Sih, T, Mion, O. Allergic rhinitis in the child and associated comorbidities. Pediatr Allergy Immunol 2010;21:e107e113 CrossRefGoogle ScholarPubMed
5 Vinke, JG, KleinJan, A, Severijnen, LW, Hoeve, LJ, Fokkens, WJ. Differences in nasal cellular infiltrates between allergic children and age-matched controls. Eur Respir J 1999;13:797803 Google Scholar
6 Kurup, VP, Barrios, CS. Immunomodulatory effects of curcumin in allergy. Mol Nutr Food Res 2008;52:1031–9Google Scholar
7 Bozdemir, K, Şahin, E, Altintoprak, N, Muluk, NB, Cengiz, BP, Acar, M et al. Is resveratrol therapeutic when used to treat allergic rhinitisinitis in rats? Clin Invest Med 2016;39: E6372 Google Scholar
8 Hancı, D, Altun, H, Çetinkaya, EA, Muluk, NB, Cengiz, BP, Cingi, C. Cinnamaldehyde is an effective anti-inflammatory agent for treatment of allergic rhinitis in a rat model. Int J Pediatr Otorhinolaryngol 2016;84:81–7Google Scholar
9 Xu, YY, Liu, X, Dai, LB, Zhou, SH. Effect of Tong Qiao drops on the expression of eotaxin, IL-13 in the nasal mucosa of rats with allergic rhinitis. J Chin Med Assoc 2012;75:524–9CrossRefGoogle Scholar
10 Tsumuro, T, Ogawa, M, Minami, K, Takubo, M, Rahman, A, Fujii, Y et al. Effects of mometasone furoate on a rat allergic rhinitis model. Eur J Pharmacol 2005;524:155–8Google Scholar
11 Mizutani, N, Nabe, T, Takenaka, H, Kohno, S. Acquired nasal hyperresponsiveness aggravates antigen-induced rhinitis in the guinea pig. J Pharmacol Sci 2003;93:437–45Google Scholar
12 Brozmanová, M, Calkovský, V, Plevková, J, Bartos, V, Plank, L, Tatár, M. Early and late allergic phase related cough response in sensitized guinea pigs with experimental allergic rhinitis. Physiol Res 2006;55:577–84Google Scholar
13 Tirkey, N, Kaur, G, Vij, G, Chopra, K. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol 2005;5:15 Google Scholar
14 Bahekar, PC, Shah, JH, Ayer, UB, Mandhane, SN, Thennati, R. Validation of guinea pig model of allergic rhinitis by oral and topical drugs. Int Immunopharmacol 2008;8:1540–51Google Scholar
15 Bengmark, S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipoxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006;30:4551 Google Scholar
16 Surh, YJ, Chun, KS, Cha, HH, Han, SS, Keum, YS, Park, KK et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001;480–481:243–68Google Scholar
17 Wallace, JM. Nutritional and botanical modulation of the inflammatory cascade – eicosanoids, cyclooxygenases, and lipoxygenases--as an adjunct in cancer therapy. Integr Cancer Ther 2002;1:737; discussion 37Google Scholar
18 Jovanovic, SV, Boone, CW, Steenken, S, Trinoga, M, Kaskey, RB. How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc 2001;123:3064–8Google Scholar
19 Kang, BY, Song, YJ, Kim, KM, Choe, YK, Hwang, SY, Kim, TS. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 1999;128:380–4Google Scholar
20 Stolina, M, Sharma, S, Lin, Y, Dohadwala, M, Gardner, B, Luo, J et al. Specific inhibition of cyclooxygenase-2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 2000;164:361–70CrossRefGoogle ScholarPubMed
21 Ram, A, Das, M, Ghosh, B. Curcumin attenuates allergen-induced hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull 2003;26:1021–4CrossRefGoogle ScholarPubMed
22 Pulla Reddy, AC, Sudharshan, E, Appu Rao, AG, Lokesh, BR. Interactions of curcumin with human serum albumin: a spectroscopic study. Lipids 1999;34:1025–9Google Scholar
23 Choi, YH, Yan, GH, Chai, OH, Song, CH. Inhibitory effects of curcumin on passive cutaneous anaphylactoid response and compound 48/80-induced mast cell activation. Anat Cell Biol 2010;43:3643 Google Scholar
24 Thakare, VN, Osama, M, Naik, SR. Therapeutic potential of curcumin in experimentally induced allergic rhinitis in guinea pigs. Int Immunopharmacol 2013;17:1825 CrossRefGoogle ScholarPubMed
25 Baek, OS, Kang, OH, Choi, YA, Choi, SC, Kim, TH, Nah, YH et al. Curcumin inhibits protease-activated receptor-2 and-4-mediated mast cell activation. Clin Chim Acta 2003;338:135–41Google Scholar
26 Lee, JH, Kim, JW, Ko, NY, Mun, SH, Her, E, Kim, BK et al. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J Allergy Clin Immunol 2008;121:1225–31CrossRefGoogle ScholarPubMed
27 Kalesnikoff, J, Galli, SJ. New developments in mast cell biology. Nat Immunol 2008;9:1215–23Google Scholar
28 Aggarwal, BB, Harikumar, KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009;41:4059 CrossRefGoogle ScholarPubMed